Anavex Life Sciences
AVXL
#7865
Rank
HK$2.47 B
Marketcap
HK$27.74
Share price
-6.32%
Change (1 day)
-70.61%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): -HK$4.21

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is -HK$4.21. In 2024 the company made an earnings per share (EPS) of -HK$4.05 an increase over its 2023 EPS that were of -HK$4.68.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$4.213.9%
2024-HK$4.05-13.33%
2023-HK$4.68-3.23%
2022-HK$4.8314.81%
2021-HK$4.2120%
2020-HK$3.51-16.67%
2019-HK$4.2138.46%
2018-HK$3.0418.18%
2017-HK$2.57-21.43%
2016-HK$3.27-35.38%
2015-HK$5.07-36.27%
2014-HK$7.95112.5%
2013-HK$3.74-58.62%
2012-HK$9.04-0%
2011-HK$9.04-29.27%
2010-HK$12.7851.85%
2009-HK$8.42-0%
2008-HK$8.42237.5%
2007-HK$2.49
2006N/A-100%
2005-HK$0.31499.97%
2004-HK$0.05195

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
HK$18.62-542.59%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-HK$0.39-90.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
HK$7.79-285.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-HK$233.00 5,437.04%๐Ÿ‡บ๐Ÿ‡ธ USA